Mutant calreticulin causes essential thrombocythemia

被引：0
|
作者：
Shimoda, Kazuya [1 ]
Shide, Kotaro [1 ]
Kameda, Takuro [1 ]
机构：
[1] Miyazaki Univ, Fac Med, Dept Gastroenterol & Hematol, Miyazaki, Japan
来源：
ONCOTARGET | 2017年 / 8卷 / 51期
关键词：
CALR; JAK2; MYELOPROLIFERATIVE NEOPLASMS; THROMBOPOIETIN RECEPTOR; ACTIVATION;
D O I：
10.18632/oncotarget.21292
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：88251 / 88252
页数：2
相关论文
共 50 条
  • [1] Calreticulin mutant mice develop essential thrombocythemia that is ameliorated by the JAK inhibitor ruxolitinib
    Shide, K.
    Kameda, T.
    Yamaji, T.
    Sekine, M.
    Inada, N.
    Kamiunten, A.
    Akizuki, K.
    Nakamura, K.
    Hidaka, T.
    Kubuki, Y.
    Shimoda, H.
    Kitanaka, A.
    Honda, A.
    Sawaguchi, A.
    Abe, H.
    Miike, T.
    Iwakiri, H.
    Tahara, Y.
    Sueta, M.
    Hasuike, S.
    Yamamoto, S.
    Nagata, K.
    Shimoda, K.
    LEUKEMIA, 2017, 31 (05) : 1136 - 1144
  • [2] Calreticulin in Essential Thrombocythemia: StressINg OUT the Megakaryocyte Nucleus
    Jose Iborra, Francisco
    Papadopoulos, Petros
    FRONTIERS IN ONCOLOGY, 2017, 7
  • [3] Alterations of Signaling Pathways in Essential Thrombocythemia with Calreticulin Mutation
    Hui, Wuhan
    Zhang, Wei
    Liu, Congyan
    Wan, Suigui
    Sun, Wanling
    Su, Li
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 6231 - 6238
  • [4] Diversities of Calreticulin Gene Mutations in Macedonian Patients With Essential Thrombocythemia
    Panovska-Stavridis, Irina
    Eftimov, Aleksandar
    Ivanovski, Martin
    Stojanovic, Aleksandar
    Georgievski, Borce
    Cevreska, Lidija
    Dimovski, Aleksandar J.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (08): : 477 - 481
  • [5] Calreticulin mutations and long-term survival in essential thrombocythemia
    Tefferi, A.
    Wassie, E. A.
    Lasho, T. L.
    Finke, C.
    Belachew, A. A.
    Ketterling, R. P.
    Hanson, C. A.
    Pardanani, A.
    Gangat, N.
    Wolanskyj, A. P.
    LEUKEMIA, 2014, 28 (12) : 2300 - 2303
  • [6] Calreticulin variant stratified driver mutational status and prognosis in essential thrombocythemia
    Elala, Yoseph C.
    Lasho, Terra L.
    Gangat, Naseema
    Finke, Christy
    Barraco, Daniela
    Haider, Mahnur
    Abou Hussein, Ahmed K.
    Hanson, Curtis A.
    Ketterling, Rhett P.
    Pardanani, Animesh
    Tefferi, Ayalew
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (05) : 503 - 506
  • [7] Structural and Dynamic Differences between Calreticulin Mutants Associated with Essential Thrombocythemia
    Radjasandirane, Ragousandirane
    de Brevern, Alexandre G.
    BIOMOLECULES, 2023, 13 (03)
  • [8] Comparison of Clinical and Hematological Parameters of Janus Kinase 2, Calreticulin or Myeloproliferative Leukemia Virus Oncogene Mutant Essential Thrombocythemia and Triple-Negative Essential Thrombocythemia
    Yildiz, Jale
    Batgi, Hikmettullah
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (03)
  • [9] Calreticulin mutation does not contribute to disease progression in essential thrombocythemia by inhibiting phagocytosis
    Daitoku, Shinya
    Takenaka, Katsuto
    Yamauchi, Takuji
    Yurino, Ayano
    Jinnouchi, Fumiaki
    Nunomura, Takuya
    Eto, Tetsuya
    Kamimura, Tomohiko
    Higuchi, Masakazu
    Harada, Naoki
    Saito, Noriyuki
    Miyamoto, Toshihiro
    Iwasaki, Hiromi
    Akashi, Koichi
    EXPERIMENTAL HEMATOLOGY, 2016, 44 (09) : 817 - 825
  • [10] Rebound of platelet count in a patient with type 2 calreticulin-mutant essential thrombocythemia in the postpartum period A case report
    Al-Mashdali, Abdulrahman F.
    Yassin, Mohamed A.
    MEDICINE, 2021, 100 (44)
12345